Becton, Dickinson and Company (BDX) FY2025 Q3 P&L / Income Statement

Becton, Dickinson and Company (BDX) FY2025 Q3 P&L / Income Statement

Income statement for 2025-04-01 through 2025-06-30. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Revenues

5,509,000,000 US dollars

Cost of products sold

2,875,000,000 US dollars

Gross profit (calculated)

2,634,000,000 US dollars

Operating expenses (calculated)

1,752,000,000 US dollars

Operating Income

882,000,000 US dollars

Other income (expense), net (calculated)

negative 179,000,000 US dollars

Income Before Income Taxes

703,000,000 US dollars

Income tax provision

129,000,000 US dollars

Net Income

574,000,000 US dollars

Medical

2,927,000,000 US dollars

Life Sciences

1,254,000,000 US dollars

Interventional

1,328,000,000 US dollars

Integration, restructuring and transaction expense

97,000,000 US dollars

Research and development expense

297,000,000 US dollars

Selling and administrative expense

1,320,000,000 US dollars

Other operating expense, net

38,000,000 US dollars

Chart connections

• Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
• Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.